Stock Events

Stock Events

EOM Pharmaceutical 

$0.2000
9
+$0.00+0% 18:34 Today

Statistics

Day High
0.2
Day Low
0.2
52W High
0.34
52W Low
0.036
Volume
100
Avg. Volume
7,557
Mkt Cap
25.3M
P/E Ratio
0.02
Dividend Yield
-
Dividend
-

Earnings

23NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.03
-0.02
-0.01
0
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMUC. It's not an investment recommendation.
Bitcoin
2
BTC.CRYPTO
Ethereum
2
ETH.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb is a leading biopharmaceutical company focusing on cancer, a key area for EOM Pharmaceutical, making them direct competitors in oncology treatments.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. specializes in pharmaceuticals, including cancer treatments that directly compete with EOM Pharmaceutical's oncology-focused pipeline.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global biopharmaceutical company with a broad range of products, including oncology, which competes with EOM Pharmaceutical's cancer treatment research.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, Inc. focuses on antiviral drugs for infections like HIV, liver diseases, and oncology, competing with EOM Pharmaceutical in the development of treatments for cancer.
AMGEN
AMGN
Mkt Cap201.93B
Amgen Inc. is a biotechnology company focusing on human therapeutics, including oncology, which competes with EOM Pharmaceutical's focus on cancer treatments.
Novartis
NVS
Mkt Cap305.1B
Novartis AG is a global healthcare company that operates in various segments, including innovative medicines with a strong focus on oncology, competing with EOM Pharmaceutical.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie Inc. is a research-based biopharmaceutical company with a significant focus on oncology, directly competing with EOM Pharmaceutical in cancer treatment research.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics in oncology, making it a competitor to EOM Pharmaceutical in cancer treatment advancements.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in oncology, competing with EOM Pharmaceutical.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson is a diverse healthcare company with a strong pharmaceutical division focusing on oncology among other areas, competing with EOM Pharmaceutical in developing cancer treatments.

About

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey.
Show more...
CEO
Dr. Irach B. Taraporewala B.S., M.S., Ph.D.
Employees
3
Country
United States
ISIN
US4525364026

Listings

OTC Link
US
IMUC

0 Comments

Share your thoughts

FAQ

What is EOM Pharmaceutical stock price today?▼
The current price of IMUC is $0.20 USD — it has increased by +0% in the past 24 hours. Watch EOM Pharmaceutical stock price performance more closely on the chart.
What is EOM Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange EOM Pharmaceutical stocks are traded under the ticker IMUC.
Is EOM Pharmaceutical stock price growing?▼
IMUC stock has fallen by -0% compared to the previous week, the month change is a -25.93% fall, over the last year EOM Pharmaceutical has showed a +198.51% increase.
What is EOM Pharmaceutical market cap?▼
Today EOM Pharmaceutical has the market capitalization of 25.3M
What were EOM Pharmaceutical earnings last quarter?▼
IMUC earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is EOM Pharmaceutical revenue for the last year?▼
EOM Pharmaceutical revenue for the last year amounts to 0 USD.
What is EOM Pharmaceutical net income for the last year?▼
IMUC net income for the last year is -1.92M USD.
How many employees does EOM Pharmaceutical have?▼
As of July 09, 2026, the company has 3 employees.
In which sector is EOM Pharmaceutical located?▼
EOM Pharmaceutical operates in the Health & Wellness sector.
When did EOM Pharmaceutical complete a stock split?▼
The last stock split for EOM Pharmaceutical was on September 16, 2020 with a ratio of 1:10.
Where is EOM Pharmaceutical headquartered?▼
EOM Pharmaceutical is headquartered in Montvale, United States.